Heregulin-induced cell migration is prevented by trastuzumab and trastuzumab-emtansine in HER2+ breast cancer. Mondaca JM, Guijarro ACC, Flamini MI, Sanchez AM, et al. Breast Cancer Res Treat 2021 Jan 20. pii: 10.1007/s10549-020-06089.

Read + Share

Amedeo Smart

Independent Medical Education

Mondaca JM, Guijarro ACC, Flamini MI, Sanchez AM, et al. Heregulin-induced cell migration is prevented by trastuzumab and trastuzumab-emtansine in HER2+ breast cancer. Breast Cancer Res Treat 2021 Jan 20. pii: 10.1007/s10549-020-06089.
PMID: 33474679